Skip to main content
. 2021 Jan 19;32:100720. doi: 10.1016/j.eclinm.2020.100720

Table 2.

Body composition and dose of ivermectin-treated participants.

Participant ID Age Sex Weight Height BMI Adipose weigh Adipose weight* 3-mg tablets received Total dose Dose/kg Dose adipose/kg
years M/F kg m kg/m2 % kg tablets mg mcg/kg mcg/kg
SAINT-5 24 Male 65·1 1·77 20·8 0·14 9·11 9 27 415 2963
SAINT-17 22 Male 72·7 1·79 22·7 0·17 12·43 10 30 413 2413
SAINT-18 18 Female 57·0 1·75 18·6 0·21 11·97 8 24 421 2005
SAINT-19 18 Female 45·1 1·55 18·8 0·21 9·61 6 18 399 1874
SAINT-3 33 Male 71·0 1·70 24·6 0·21 15·48 10 30 423 1938
SAINT-21 18 Female 50·1 1·60 19·6 0·22 11·47 7 21 419 1830
SAINT-16 20 Female 49·2 1·59 19·5 0·23 11·37 7 21 427 1848
SAINT-9 28 Male 89·9 1·79 28·1 0·26 23·82 12 36 400 1511
SAINT-11 47 Male 85·8 1·77 27·4 0·27 23·77 12 36 420 1515
SAINT-20 29 Male 92·2 1·79 28·8 0·27 25·54 13 39 423 1527
SAINT-8 39 Male 93·6 1·77 29·9 0·30 28·27 13 39 417 1380
SAINT-13 57 Female 66·0 1·57 26·6 0·39 26·27 9 27 409 1028